Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 1;98(2):E205-E212.
doi: 10.1002/ccd.29649. Epub 2021 Mar 24.

Trends in the utilization and reimbursement of coronary revascularization in the United States Medicare population from 2010 to 2018

Aakash M Shah  1 , Emaad Siddiqui  2 , Carlos Cuenca  1 , Persida Drotar  3 , Alexis K Okoh  3 , Arash Salemi  3 , Sergio Waxman  4 , Justin Sambol  1
Affiliations

Trends in the utilization and reimbursement of coronary revascularization in the United States Medicare population from 2010 to 2018

Aakash M Shah et al. Catheter Cardiovasc Interv. .

Abstract

Objective: To determine utilization and reimbursement trends of coronary revascularization procedures in the US Medicare population from 2000 to 2018.

Background: US Medicare population is increasing, and coronary revascularization decreased in the 2000s.

Methods: This is a population-based, cross sectional study of US Medicare beneficiaries from 2010 to 2018. The Centers for Medicare and Medicaid Services' database was queried for revascularization procedures using the coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) current procedural terminology (CPT) codes. Trends in Medicare enrollees, PCIs, CABGs, and physician reimbursements were analyzed.

Results: Total utilization and reimbursement decreased for both revascularization procedures. The national CABG and PCI utilization per enrollee has decreased by 40.7% (best fit line: b coefficient, 95% CI; -0.297, -0.358 to -0.235) and 26.4% (best fit line: -0.229, -0.373 to -0.0858), respectively. For CABG, annual Medicare payout per enrollee and physician compensation per procedure has decreased by 49.3% (best fit line: -0.250, -0.315 to -0.185) and 14.5% (best fit line: -11.54, -15.62 to -7.452), respectively, and for PCI, decreased by 53.3% (best fit line: -0.373, -0.560 to -0.186) and 36.6% (best fit line: -34.15, -49.35 to -18.95), respectively. Amongst the states, there was significant variability in procedure utilization, and CABG reimbursement rates but minimal variability in PCI reimbursement rates.

Conclusion: Even though the US population has aged, revascularization utilization and reimbursement continue to decline. Advancement in medical intervention strategies, particularly non-surgical management, may account for these trends. Further understanding of these trends will allow health systems to tailor resources to the aging population.

Keywords: coronary artery bypass grafting; coronary artery disease; percutaneous coronary intervention.

PubMed Disclaimer

Comment in

  • Ordering from the bill instead of from the menu.
    Goldsweig AM, Secemsky E, Wadhera R, Cohen DJ. Goldsweig AM, et al. Catheter Cardiovasc Interv. 2021 Nov 15;98(6):1141-1143. doi: 10.1002/ccd.29822. Epub 2021 Jun 17. Catheter Cardiovasc Interv. 2021. PMID: 34138515 No abstract available.

References

REFERENCES

    1. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):1-12. https://doi.org/10.21037/atm.2016.06.33.
    1. Zhang Z, Kolm P, Grau-Sepulveda MV, et al. Cost effectiveness of revascularization strategies: results from the American College of Cardiology Foundation and the Society of Thoracic Surgeons collaboration on the comparative effectiveness of revascularization strategies (ASCERT). J Am Coll Caradiol. 2015;65(1):1-11. https://doi.org/10.1016/j.physbeh.2017.03.040.
    1. Ryan J, Cohen DJ. Are drug-eluting stents cost-effective? It depends on whom you ask. Circulation. 2006;114(16):1736-1743. https://doi.org/10.1161/CIRCULATIONAHA.105.546010.
    1. Schmidt T, Abbott J. Coronary stents: history, design, and construction. J Clin Med. 2018;7(6):126. https://doi.org/10.3390/jcm7060126.
    1. Lai CH, Lee WL, Sung SH, et al. Comparison of bare-metal stent and drug-eluting stent for the treatment of patients undergoing percutaneous coronary intervention for unprotected left main coronary artery disease - long-term result from a single center experience. Acta Cardiol Sin. 2015;31(5):381-389. https://doi.org/10.6515/ACS20140630G.